4//SEC Filing
Grant-Huerta Yanina 4
Accession 0000905148-25-003069
CIK 0001604464other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 4:08 PM ET
Size
7.8 KB
Accession
0000905148-25-003069
Insider Transaction Report
Form 4
Grant-Huerta Yanina
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-08-18$11.61/sh−86$999→ 36,926 total - Sale
Common Stock
2025-08-18$11.61/sh−1,668$19,372→ 35,258 total - Sale
Common Stock
2025-08-18$11.61/sh−55$638→ 37,012 total
Footnotes (2)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 18, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0002064348
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 4:08 PM ET
- Size
- 7.8 KB